CONSTELLATION BRANDS (STZ) reported fiscal second-quarter adjusted earnings per share of $3.74, exceeding the Zacks Consensus Estimate of $3.62, while sales reached $2.63 billion versus analyst expectations of $2.54 billion.
The beat masks a deeper problem: full-year guidance. The company expects fiscal 2027 adjusted EPS between $11.20 and $11.90—a modest raise—but projected organic net sales growth of -1 percent to +1 percent. That flat outlook has spooked the market.
STZ closed at $116.06 on Oct. 6, up 2.43 percent for the day but still 31 percent below its 52-week high of $168.60 and only 5 percent above its 52-week low of $110.60. The stock's valuation now sits near its 10-year low—a capitulation point that typically attracts opportunistic buyers.
Analysts have cut price targets in response to volume headwinds. The market demands proof: higher beer volumes, margin expansion, and clearer full-year visibility before re-rating the stock higher.
Year-over-year, adjusted EPS rose 3 percent (from $3.63 in prior fiscal Q2), while revenue climbed 6 percent from $2.48 billion. The growth is real, but it's not enough to offset investor anxiety over consumer softness in the beer category.
Conviction play: STZ trades at distressed valuation despite a resilient business. Corona, Modelo, and Pacifico dominate U.S. beer; the wine and spirits units (Robert Mondavi, Kim Crawford, Casa Noble) generate stable cash flow. If volume trends stabilize in the next quarter, the stock could re-rate 20-25 percent on mean reversion alone. For now, the risk-reward favors nibbling.
